Fall 2021 | Boston, MA
4 packed content tracks
RESEARCH & DISCOVERY
Enhanced targeting, process improvement, using predictive analytics to rank and prioritize assets in the move toward more personalized medicines, collaboration models as a vital component to a fundamental commitment to R&D.
ADME Tox, Pharmacovigilance, Patient Recruitment, Adherence and Retention in Clinical Trials, Digital Therapeutics and Virtual and Hybrid Trials.
How organizations are using genomic data in specific therapeutic areas; What insights are being drawn from genomic data sets; What information is being parsed and what's useful in enabling outcomes.
STRATEGY & LEADERSHIP
For scientific and technology leaders - where the industry is headed, what is needed to move faster, how shifts in business models, organizational structure, automation, and talent management are important in driving the industry forward.
Past and current speakers
The content, attendees and level of speakers at the AI in Biopharma Summit make it a must attend for those who are looking at AI with a more critical eye in this post-hype era.
Martin Akerman, Co-Founder & CTO, Envisagenics